Effects of morphine in rats withdrawn from repeated nifedipine administration

European Journal of Pharmacology
T P PiepponenL Ahtee

Abstract

The effects of withdrawal from repeated nifedipine treatment on morphine-induced analgesia, hyperthermia and catalepsy as well as on cerebral [3H]nitrendipine binding and on morphine-induced changes in striatal and limbic dopamine and 5-hydroxytryptamine metabolism were studied in rats. Repeated administration of nifedipine (5 mg/kg i.p., twice daily for 14 days) decreased [3H]nitrendipine binding in several brain areas of the rats at 24 h after the last dose but did not change the nociceptive response or rectal temperature of the animals. Further, the antinociceptive potency of acute morphine (2.5 mg/kg s.c.) was significantly reduced in rats withdrawn for 24 h from repeated nifedipine treatment. However, withdrawal from repeated nifedipine treatment failed to affect either the hyperthermia induced by this dose of morphine or the catalepsy and the elevation of dopamine or 5-hydroxytryptamine metabolites induced by 15 mg/kg of morphine. Taken together, these data show that withdrawal from repeated treatment with dihydropyridine calcium channel antagonists selectively reduces the effects of opioids on the nociceptive response.

References

May 3, 1990·European Journal of Pharmacology·L Antkiewicz-MichalukJ Vetulani
Jan 1, 1990·General Pharmacology·H F Miranda, C Paeile
May 26, 1986·Life Sciences·G W Pasternak, P J Wood
Jan 1, 1985·Regulatory Peptides. Supplement·H W KosterlitzL E Robson
Jul 1, 1986·British Journal of Pharmacology·F BongianniD E Pellegrini-Giampietro
Dec 6, 1988·European Journal of Pharmacology·T OhnishiR Inoki
Jan 1, 1988·Pharmacology·P K JanickiP Krzaścik
Apr 13, 1988·European Journal of Pharmacology·E ContrerasM Amigo
Jun 4, 1987·European Journal of Pharmacology·E Del PozoJ M Baeyens
Jun 17, 1983·European Journal of Pharmacology·M M Ben-SretiR D Sewell
Oct 1, 1984·Pharmacological Research Communications·G Benedek, M Szikszay
Aug 1, 1996·Pharmacology, Biochemistry, and Behavior·T P PiepponenL Ahtee
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·T P PiepponenL Ahtee

❮ Previous
Next ❯

Citations

Mar 3, 2005·Pharmacology, Biochemistry, and Behavior·Liza LeventhalDarlene Deecher
Mar 7, 2008·The International Journal of Neuroscience·Omid KhalilzadehMohammad R Zarrindast
May 5, 2007·Pharmacology, Biochemistry, and Behavior·Saeed Esmaeili-MahaniAbolhassan Ahmadiani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.